Legal Affairs

Jazz Pharmaceuticals: The Medical Cannabis Insider Nearing $1B Milestone

DUBLIN – Jazz Pharmaceuticals reported a 20% jump in Q3 2025 sales for its cannabidiol-based epilepsy drug Epidiolex®, pushing the product's YTD revenue past $772 million and underscoring the company's steady position in the medical ...

Medicare Explores CBD Coverage for Seniors

WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) is set to roll out a pilot program that could extend coverage to cannabidiol (CBD) treatments for certain older Americans, marking a cautious step by ...

How to Make the Most of MJBizCon? Take Full Advantage of LinkedIn

LOS ANGELES- Each year, the global Cannabis industry converges on Las Vegas for MJBizCon Dec 2-5 in the Las Vegas Convention Center—a concentrated, high-value moment where operators, investors, executives, retailers, lenders, lawyers, accountants, manufacturers, and ...

Rhode Island Launched Applications for Additional Cannabis Retail Licenses

PROVIDENCE – The Rhode Island Cannabis Control Commission has started taking applications for 24 additional adult-use Cannabis retail licenses, a step that expands the state's recreational market three years after legalization. The licenses are spread ...

Week In Review: Cannabis & Psychedelics Industry Highlights

LOS ANGELES – Wrapping up the first half of September 2025, it's worth noting that the Cannabis & Psychedelics industries continue proving their resilience amid political uncertainty and turbulent market dynamics. From stock rallies signaling ...

Former Arizona Senator Sinema Advocates Ibogaine Research Post-Treatment

LOS ANGELES – Former U.S. Senator Kyrsten Sinema of Arizona shared details of her personal encounter with ibogaine during a recent appearance on CNN. Speaking with Jake Tapper, Sinema highlighted her push for expanded research into ...